BELVIS JIMÉNEZ , María Inmaculada

Objetivos: el objetivo principal del estudio fue evaluar la variabilidad interobservador para el Índice de Mayo Endoscópico (IME), el Índice de Severidad Endoscópica de la Colitis Ulcerosa (UCEIS) y el Índice de Severidad Colonoscópica de la Colitis Ulcerosa (UCCIS), que analizan la gravedad de las lesiones endoscópicas en los pacientes...

Introduction: endoscopy plays an essential role in the management of patients with ulcerative colitis (UC), as it allows us to visualize and assess the severity of the dis ease. Different scores have been devised to standardize the findings because such assessments are not always objective. Aims: the aim of this study was to assess the...

Background: vedolizumab is an α4β7 integrin antagonist. The aim of this study was to evaluate the clinical response and remission rates with vedolizumab. Methods: this was a retrospective study of inflammatory bowel disease (IBD) patients who received vedolizumab between 2016 and 2019. Response and remission rates were analyzed at three,...

Background and study aims: Endoscopy plays an essential role in managing patients with ulcerative colitis (UC), as it allows us to visualize and assess the severity of the disease. As such assessments are not always objective, different scores have been devised to standardize the findings. The main aim of this study was to assess the...